Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Molecular Therapeutics Overview Sparkline Graph

Graph co-Publications by faculty members in Molecular Therapeutics

Show all Molecular Therapeutics members

Publications (total of 2115)

no pagination
Freedman GM, Anderson PR, Li JS, Eisenberg DF, Hanlon AL, Wang L, Nicolaou N. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2006 Feb;29(1):66-70.
Goldstein LJ. Controversies in adjuvant endocrine treatment of premenopausal women. Clinical Breast Cancer. 2006 Feb;6 Suppl 2:S36-40.
Pfister DG, Ridge JA. Induction chemotherapy for larynx preservation: Patient selection or therapeutic effect?. JOURNAL OF CLINICAL ONCOLOGY. 2006 Feb;24(4):540-3.
Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma CM, McNeeley SW, Buyyounouski MK, Price RA. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Feb;64(2):518-26.
Pugacheva EN, Golemis EA. HEF1-Aurora A interactions - Points of dialog between the cell cycle and cell attachment signaling networks. Cell cycle (Georgetown, Tex). 2006 Feb;5(4):384-91.
Adams GP, Tai M, McCartney JE, Marks JD, Stafford WF, Houston LL, Huston JS, Weiner LM. Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv Dimers. Clinical Cancer Research. 2006 Jan;12(5):1599-605.
Borghaei H, Robinson MK, Weiner LM. Monoclonal antibody therapy of cancer. In: Disis ML, editor. Immunotherapy of cancer. Totowa, N.J.: Humana Press; 2006. p. 487-502.
Fourkal E, Velchev I, Ma CM, Smolyakov A. Evanescent wave interference and the total transparency of a warm high-density plasma slab. PHYSICS OF PLASMAS. 2006 Jan;13(9):Art.
Khazak V, Kato-Stankiewicz J, Tamanoi F, Golemis EA. Yeast screens for inhibitors of Ras-Raf interaction and characterization of MCP inhibitors of Ras-Raf interaction. In: REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY Book series title: METHODS IN ENZYMOLOGY. 2006. p. 612-29.
Langer CJ, Duffy K, Horwitz EM, Litwin S, Rosvold E, Schol J, Keenan E, Nicolaou N, Friedman CD, Ridge JA. Phase I Trial of Concurrent Hyperfractionated Split Course Radiotherapy (HFx RT), Cisplatin (cDDP), and Paclitaxel in Patients with Recurrent, Previously Irradiated, or Treatment-Naive Locally Advanced Upper Aerodigestive Malignancy. Cancer Invest. 2006 Jan;24(2):164-73.
Lango M, Chalian AA. Overview of head and neck cancer. In: Calhoun KH, Eibling DE, editors. Geriatric otolaryngology. New York: Taylor & Francis; 2006. p. 471-82.
Latypov RF, Cheng H, Roder NA, Zhang J, Roder H. Structural Characterization of an Equilibrium Unfolding Intermediate in Cytochrome c. Journal of Molecular Biology. 2006 Jan;357(3):1009-25.
Ma CM, Paskalev K. In-room CT techniques for image-guided radiation therapy. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2006 Jan;31(1):30-9.
Ma CM, Veltchev I, Fourkal E, Li JS, Luo W, Fan J, Lin T, Pollack A. Development of a laser-driven proton accelerator for cancer therapy. Laser Physics. 2006 Jan;16(4):639-46.
Narra K, Borghaei H, Al-Saleem T, Hoglund M, Smith MR. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leukemia Research. 2006 Jan;30(1):109-14.
Sagil O, Wolfson M, Cohen A, Izumchenko E, Golemis EA, Fraifeld VE. Shc proteins and brain functions: possible implications for neuroprotection. IJNN. 2006 Jan;3(1):12-20.
Wang G, Sauder JM, Dunbrack RL. Comparative modeling and structural proteomics. Structural Genomics and High Throughput Structural Biology. 2006 Jan;:109-36.
Wang L, Li JS, Paskalev K, Hoban P, Luo W, Chen LL, McNeeley S, Price R, Ma C. Commissioning and quality assurance of a commercial stereotactic treatment-planning system for extracranial IMRT. Journal of Applied Clinical Medical Physics. 2006 Jan;7(1):21-34.
Weiner LM, Borghaei H. Targeted therapies in solid tumors: Monoclonal antibodies and small molecules. Hum Antibodies. 2006 Jan;15(3):103-11.
Yuan Q, Simmons HH, Robinson MK, Russeva M, Marasco WA, Adams GP. Development of engineered antibodies specific for the Muellerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Molecular Cancer Therapeutics. 2006 Jan;5(8):2096-105.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications by faculty members in Molecular Therapeutics


Show All Units
Last updated on Friday, January 03, 2020